Breast Pathology Treatment and Drugs

Breast cancer treatment team mainly includes Breast surgeon, surgical oncologist, radiation oncologist, medical oncologist, plastic surgeon. It also includes a variety of other health care professionals, including physician assistants, oncology nurses, social workers, pharmacists, counsellors, nutritionists, and others. The biology and behaviour of a breast cancer affects the treatment plan. Treatment options and recommendations are very personalized and depend on several factors, including: stage of tumour, tumour subtypes, genomic maker, patient age, and patient menopausal status, mutations in inherited breast cancer genes, such as BRCA1 or BRCA2. For both DCIS and early-stage invasive breast cancer, doctors generally perform surgery to remove the tumour. For larger cancers, or those that are growing more quickly, doctors may recommend systemic treatment with chemotherapy or hormonal therapy before surgery, called neoadjuvant therapy.

  • Chemotherapy
  • Radiation therapy
  • Reconstructive (plastic) surgery
  • Hormonal therapy
  • Targeted therapy

Related Conference of Breast Pathology Treatment and Drugs

March 20-21, 2019

International Conference on Molecular Pathology

Paris | France
April 22-23, 2019

16th Annual Conference on Laboratory Medicine & Pathology

Kuala Lumpur, Malaysia
May 9-10, 2019

17th European Pathology Congress

| Amsterdam, Netherlands
June 28-29, 2019

Breast Pathology 2019

Oslo, Norway
July 29-30, 2019

17th Asia Pacific Pathology Congress

Mercure Albert Park, Melbourne, Australia
November 08 09, 2019

18th Global Congress on Pathology

San Francisco | California | United States
November 19-20, 2019

2nd European Pathology and Infectious Disease Conference

Helsinki, Finland

Breast Pathology Treatment and Drugs Conference Speakers

Recommended Sessions

Related Journals

Are you interested in